- Pfizer plans to test a coronavirus vaccine in thousands of people by September.
- CEO Albert Bourla said that if a vaccine proves to be safe, the company “will be able to deliver millions of doses in the October time frame.”
Pfizer CEO and Chairman Albert Bourla said Tuesday that the company plans to expand human trials of its experimental coronavirus vaccine to thousands of test patients by September.
The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, injected doses of its potential vaccine, BNT162, into the first human participants in the U.S. last week. The company said it hopes to test up to 360 people in the clinical trial.
Pfizer is currently testing four different vaccine variations, Bourla said during CNBC’s Healthy Returns Virtual Summit.
“We are collecting data as we speak in real time so we know, we are monitoring the safety of the doses,” Bourla said. Pfizer will have conclusive data on which vaccine variation stands out in June or July, Bourla said.
If one or two variations indicate success, the company will ramp up trials, and then in September launch a broad large-scale study with thousands of participants if a vaccine proves to be successful, he added.
“If things go well, and we feel that the product is safe and efficacious, and the FDA [Food and Drug Administration] and EMA [European Medicines Agency] and other regulatory agencies feel the same, we will be able to deliver millions of doses in the October time frame,” Bourla said.
The company plans to produce hundreds of millions of doses in 2021, he added.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
Prime Minister Shinzo Abe says more than 30 countries have asked Japan for favipiravir (Avigan) to fight Covid 19
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters